Pharma IQ Members

Resource Centre - Pred Tox Academy

Case Study: Developing Predictive Liver Models from Pluripotent Stem Cells

David
This FREE webinar was recorded on:
Monday, November 21, 2016
03:00 PM - 04:00 PM GMT
Sign Up for Webinar

The development of renewable human liver models, from genetically defined origins, is likely to be a game-changing addition to the field of Predictive Toxicology. However, for these models to have significant impact they must be stable in character and capable of manufacture at scale.

For this reason, we have chosen to use pluripotent stem cells (PSCs). We have developed highly efficient, scalable, and reliable differentiation procedures for use with PSCs, which demonstrate very promising qualities.

In collaboration with industry and academic laboratories, we provide proof of concept that stem cell derived hepatocytes are scalable and metabolise drugs. In addition, our stem cell based systems possess an intact innate immune system and are capable of predicting human drug-induced liver injury, in line with current gold standard human models. Our most recent advances will be discussed at the meeting.

When: 21st November at 3pm GMT

How: Register for this webinar using the button above and you will recieve instructions on how to attend this live webinar. 

About the Predictive Toxicology Academy:  Following a series of successful real world conferences, to aid worldwide accessibility the Predictive Toxicology Academy brings you an evolving hub of online resources all accessible from the comfort of your desk. This November, the Academy will grow to become a library hosting a portfolio of various multimedia including live interactive sessions, whitepapers, podcasts, infographics, articles and interviews. Each week will have a fresh topic of focus within predictive toxicology.

Register for updates for the Predictive Toxicology Academy here today. 

Have Your Say
Rate this feature and give us your feedback in the comments section below
Presenter:
David
David Hay
Principal Investigator
University of Edinburgh’s MRC Centre for Regenerative Medicine

Dr David Hay is a Principal Investigator at the University of Edinburgh’s MRC Centre for Regenerative Medicine. David has worked in the field of stem cell biology and differentiation over the last fifteen years. David and his team have highlighted the important role that pluripotent stem cells have to play in modelling human liver biology ‘in a dish’. 


Rate this: 
5
Average: 5 (1 vote)

Thank you, for your interest in, Case Study: Developing Predictive Liver Models from Pluripotent Stem Cells.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Forgot your password?
Not a member?

Reasons for Joining
  • Address your challenges through knowledge sharing with peers from our global network of specialists.
  • Benchmark your business initiatives with the who's who in the field.
  • Hear from industry pioneers how to maximize ROI in today's challenging economy.
  • And best of all It's FREE!
By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product.